Liver immunity and tumour surveillance

Immunology Letters

Volumn 107, Issue 2, 2006, Pages 83-88

  Canning, Caitriona ^a   O'Brien, Margaret ^a   Hegarty, John ^a,b   O'Farrelly, Cliona ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Liver; Tumour immunology; Tumour surveillance

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2; MATRIX METALLOPROTEINASE; NATURAL KILLER CELL RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANATOMY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BYSTANDER EFFECT; CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELLULAR IMMUNITY; COLORECTAL CANCER; CYTOKINE PRODUCTION; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; HUMAN; IMMUNOCOMPETENCE; INFLAMMATORY INFILTRATE; KIDNEY CARCINOMA; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER METASTASIS; LYMPHOCYTE PROLIFERATION; MELANOMA; METASTASIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOTHERAPY; LIVER; LIVER NEOPLASMS;

EID: 33751180964     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.07.002     Document Type: Review

References (38)

1. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002) 563-572
2. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 163 (1999) 2314-2321
3. Tanaka Y., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., and Bloom B.R. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375 (1995) 155-158
4. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 21 (2000) 573-583
5. Mackay I.R. Hepatoimmunology: a perspective. Immunol Cell Biol 80 (2002) 36-44
6. Thomson A.W., O'Connell P.J., Steptoe R.J., and Lu L. Immunobiology of liver dendritic cells. Immunol Cell Biol 80 (2002) 65-73
7. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
8. + T cells in patients with malignancy. Clin Exp Immunol 97 (1994) 522-527
9. Lanier L.L., Corliss B., and Phillips J.H. Arousal and inhibition of human NK cells. Immunol Rev 155 (1997) 145-154
10. Norris S., Doherty D.G., Curry M., McEntee G., Traynor O., Hegarty J.E., et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother 52 (2003) 53-58
11. Albertsson P.A., Basse P.H., Hokland M., Goldfarb R.H., Nagelkerke J.F., Nannmark U., et al. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol 24 (2003) 603-609
12. Brutkiewicz R.R., and Sriram V. Natural killer T (NKT) cells and their role in antitumor immunity. Crit Rev Oncol Hematol 41 (2002) 287-298
13. Kenna T., Golden-Mason L., Porcelli S.A., Koezuka Y., Hegarty J.E., O'Farrelly C., et al. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 171 4 (2003) 1775-1779
14. 2-microglobulin-associated form. Int Immunol 11 (1999) 383-392
15. Tsuneyama K., Yasoshima M., Harada K., Hiramatsu K., Gershwin M.E., and Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28 (1998) 620-623
16. Wilson J., and Balkwill F. The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12 (2002) 113-120
17. + T cells in vitro but not in vivo. Cytokine 25 (2004) 273-282
18. Radinsky R., and Ellis L.M. Molecular determinants in the biology of liver metastasis. Surg Oncol Clin N Am 5 (1996) 215-229
19. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
20. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev 13 (2002) 135-141
21. Szlosarek P.W., and Balkwill F.R. Tumour necrosis factor α: a potential target for the therapy of solid tumours. Lancet Oncol 4 (2003) 565-573
22. Piek E., and Roberts A.B. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv Cancer Res 83 (2001) 1-54
23. Sun L. Tumor-suppressive and promoting function of transforming growth factor beta. Front Biosci 9 (2004) 1925-1935
24. Akhurst R.J., and Derynck R. TGF-β signaling in cancer-a double-edged sword. Trends Cell Biol 11 (2001) S44-S51
25. Dumont N., and Arteaga C.L. The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFβ. Differentiation 70 9/10 (2002) 574-582
26. Xiong B., Yuan H.Y., Hu M.B., Zhang F., Wei Z.Z., Gong L.L., et al. Transforming growth factor-β1 in invasion and metastasis in colorectal cancer. World J Gastroenterol 8 (2002) 674-678
27. Tsushima H., Ito N., Tamura S., Matsuda Y., Inada M., Yabuuchi I., et al. Circulating transforming growth factor β1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 7 (2001) 1258-1262
28. + regulatory T cells. Semin Immunol 16 (2004) 89-97
29. Unitt E., Rushbrook S.M., Marshall A., Davies S., Gibbs P., Morris L.S., et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41 (2005) 722-730
30. Decatris M., Santhanam S., and O'Byrne K. Potential of interferon-α in solid tumours: part 1. BioDrugs 16 (2002) 261-281
31. Rosenberg S.A., Lotze M.T., Yang J.C., Topalian S.L., Chang A.E., Schwartzentruber D.J., et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 85 (1993) 622-632
32. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51-62
33. Calne R.Y., Sells R.A., Pena J.R., Davis D.R., Millard P.R., Herbertson B.M., et al. Induction of immunological tolerance by porcine liver allografts. Nature 223 (1969) 472-476
34. Kamada N., and Wight D.G.D. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 38 (1984) 217-221
35. Ramos H.C., Reyes J., Abuelmagd K., Zeevi A., Reinsmoen N., Tzakis A., et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 59 (1995) 212-217
36. Klein G., and Klein E. Surveillance against tumors-is it mainly immunological?. Immunol Lett 100 (2005) 29-33
37. Yamaguchi T., and Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol 16 (2006) 115-123
38. Sutmuller R.P., Offringa R., and Melief C.J. Revival of the regulatory T cell: new targets for drug development. Drug Discov Today 9 (2004) 310-316